CLL-1382: Comparing Ibrutinib With Acalabrutinib and Zanubrutinib in B-Cell Malignancies: A Real-World Study of Mortality and Toxicity
Year: 2026
Type: conference-abstract
Institution: University of Arkansas for Medical Sciences
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: ibrutinib, acalabrutinib, zanubrutinib, BTK inhibitors, chronic lymphocytic leukemia, Waldenström macroglobulinemia, mantle cell lymphoma, all-cause mortality, atrial fibrillation, heart failure, gastrointestinal bleeding, acute respiratory failure, endotracheal intubation, joint pain, myalgia, survival
Open Access status: closed
OpenAlex ID: W7204682132
